New news
SKTO's Medical Greens Announces New Distribution Agreement Taking Total Market Presence to Over 400 California Collectives
LOS ANGELES, CA--(Marketwired - Nov 25, 2013) - SK3 Group, Inc's (OTC Pink: SKTO) ("the Company") subsidiary Medical Greens is pleased to announce that its managed wholesale collectives portfolio has reached a new distribution agreement for the sale of the Company's products in over 400 collectives throughout California, including: Dharmanol, Canna-Loz Organic Oil, T-Hydro-Can, Yak Capsules, Yeti Honeybud Oilers, Organakoil, Red Diamond Oil, Greenie Whole Plant Cookies, Haute Chocolate Instant Drink Mix, and Mocha-juana Instant Drink Mix.
"This marks an important milestone for the growth of the company," said President Artemus Mayor. "This kind of growth is a testament to the success of our prior strategic moves and the efforts of our sales force. As we broaden the distribution of our products, we are also seeking to deepen it so watch for similar future announcements."
About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT INFORMATION
SK3 Group, Inc.
investors@medicalgreens.com
Investor Relations
SKTO's Medical Greens Announces New Distribution Agreement Taking Total Market Presence to Over 400 California Collectives
LOS ANGELES, CA--(Marketwired - Nov 25, 2013) - SK3 Group, Inc's (OTC Pink: SKTO) ("the Company") subsidiary Medical Greens is pleased to announce that its managed wholesale collectives portfolio has reached a new distribution agreement for the sale of the Company's products in over 400 collectives throughout California, including: Dharmanol, Canna-Loz Organic Oil, T-Hydro-Can, Yak Capsules, Yeti Honeybud Oilers, Organakoil, Red Diamond Oil, Greenie Whole Plant Cookies, Haute Chocolate Instant Drink Mix, and Mocha-juana Instant Drink Mix.
"This marks an important milestone for the growth of the company," said President Artemus Mayor. "This kind of growth is a testament to the success of our prior strategic moves and the efforts of our sales force. As we broaden the distribution of our products, we are also seeking to deepen it so watch for similar future announcements."
About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT INFORMATION
SK3 Group, Inc.
investors@medicalgreens.com
Investor Relations
